Your browser doesn't support javascript.
loading
Chemotherapy in Combination With Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO Guideline.
Chen, Yu-Pei; Ismaila, Nofisat; Chua, Melvin L K; Colevas, A Dimitrios; Haddad, Robert; Huang, Shao Hui; Wee, Joseph T S; Whitley, Alexander C; Yi, Jun-Lin; Yom, Sue S; Chan, Anthony T C; Hu, Chao-Su; Lang, Jin-Yi; Le, Quynh-Thu; Lee, Anne W M; Lee, Nancy; Lin, Jin-Ching; Ma, Brigette; Morgan, Thomas J; Shah, Jatin; Sun, Ying; Ma, Jun.
Afiliação
  • Chen YP; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, and Chinese Society of Clinical Oncology, Beijing, People's Republic of C
  • Ismaila N; American Society of Clinical Oncology, Alexandria, VA.
  • Chua MLK; National Cancer Centre Singapore/Duke-NUS Medical School, Singapore.
  • Colevas AD; Stanford University School of Medicine, Stanford, CA.
  • Haddad R; Dana-Farber Cancer Institute, Boston, MA.
  • Huang SH; Princess Margaret Cancer Centre/University of Toronto, Toronto, Ontario, Canada.
  • Wee JTS; National Cancer Centre Singapore/Duke-NUS Medical School, Singapore.
  • Whitley AC; Central Alabama Radiation Oncology, Montgomery, AL.
  • Yi JL; National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, and Chinese Society of Clinical Oncology, Beijing, People's Republic of China.
  • Yom SS; University of California San Francisco, San Francisco, CA.
  • Chan ATC; State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, Department of Clinical Oncology, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Hong Kong, Special Administrative Region, People's Republic of China.
  • Hu CS; Fudan University Shanghai Cancer Center, Shanghai, and Chinese Society of Clinical Oncology, Beijing, People's Republic of China.
  • Lang JY; Sichuan Cancer Hospital & Institute, Chengdu, and Chinese Society of Clinical Oncology, Beijing, People's Republic of China.
  • Le QT; Stanford University School of Medicine, Stanford, CA.
  • Lee AWM; The University of Hong Kong-Shenzhen Hospital, People's Republic of China, and The University of Hong Kong, Hong Kong, Special Administrative Region, People's Republic of China.
  • Lee N; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Lin JC; Changhua Christian Hospital, Changhua, Taiwan.
  • Ma B; State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, Department of Clinical Oncology, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Hong Kong, Special Administrative Region, People's Republic of China.
  • Morgan TJ; Patient Representative, Monmouth, NJ.
  • Shah J; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Sun Y; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, and Chinese Society of Clinical Oncology, Beijing, People's Republic of C
  • Ma J; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, and Chinese Society of Clinical Oncology, Beijing, People's Republic of C
J Clin Oncol ; 39(7): 840-859, 2021 03 01.
Article em En | MEDLINE | ID: mdl-33405943

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Nasofaríngeas / Quimiorradioterapia / Carcinoma Nasofaríngeo / Oncologia Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Revista: J Clin Oncol Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Nasofaríngeas / Quimiorradioterapia / Carcinoma Nasofaríngeo / Oncologia Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Revista: J Clin Oncol Ano de publicação: 2021 Tipo de documento: Article